9-12 months short treatment for patients with MDR-TB increases treatment success in Kyrgyzstan.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of infection in developing countries"
DOI: 10.3855/jidc.13757
Abstract: INTRODUCTION MDR/RR-TB is a growing problem in Kyrgyzstan. In 2005, the country introduced standard or individualized treatment for 20-24 months. Because of poor treatment outcomes, in 2017 a short treatment with strict eligibility criteria was… read more here.
Keywords: treatment success; standard individualized; treatment; treatment patients ... See more keywords